1 / 18

Shared Care – I n Practice

Shared Care – I n Practice. Dr Sue Pritchard Shipston Medical Centre. Substance misuse treatment in primary care- why bother?. Chronic relapsing condition – similar to others treated in primary care Mortality 14 x higher for age matched controls

zorina
Download Presentation

Shared Care – I n Practice

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Shared Care – In Practice Dr Sue Pritchard Shipston Medical Centre

  2. Substance misuse treatment in primary care- why bother? • Chronic relapsing condition – similar to others treated in primary care • Mortality 14 x higher for age matched controls • Morbidity: 90% cases of hep C in UK are associated with IVD use

  3. Why bother…. • Effective evidence based treatment with good outcomes • Needs holistic individualised approach – cornerstone of GP care • Good for our communities

  4. Effects of dependant drug use • Physical: BBV transmission, complications of injecting including VTE, abscesses, Endocarditis, Poor pregnancy outcomes, Overdose. • Social: Effects on families, criminality, imprisonment, social exclusion • Psychological: Fear of withdrawal, craving , guilt, stigma • Mental health: depression, psychosis, dual diagnosis

  5. Evidence based treatments • Reduces mortality significantly • Reduced drug related morbidity • Reduces crime • Reduces risk taking behaviour and spread of BBV • Can be done safely without increasing methadone mortality

  6. Guidelines • RCGP Guidance for the use of substitute prescribing in the treatment of opioid dependence in primary care – 2011 • Drug misuse and dependence - UK guidelines on clinical management • RCGP Certificate in the Management of Drug Misuse

  7. What is Treatment? • NTA describes range of interventions which are intended to remedy an identified drug related problem or condition relating to a person’s physical, psychological and social well being • Structured drug treatment follows assessment and is delivered with a written mutually agreed care plan, which is regularly reviewed

  8. Treatment and ‘Recovery’ • Political shift towards recovery approach which NTA frames ‘in terms of achieving an individual client’s goals for making positive changes in their lives’. • This is underpinned by more personalised approach to treatment and a balanced system including, even encouraging, abstinence orientated treatment

  9. Recovery • A patient’s unique journey • Shared care patients -often stabilised, housed, employed, family • Need opportunity to discuss reduction • ‘ Treatment should end at the point of the patient’s journey which the patient and the prescriber judge to be clinically (not politically or morally) safe and appropriate’

  10. Philosophy • More than just methadone • Therapeutic alliance • Motivational interviewing – Rollnick and Miller • Engagement – attitudinal approach throughout team • Holistic approach • Family support - ESH • Safeguarding Children • Safety of medicines • DVLA

  11. In Practice • New patients seen by SCP/PD • Contact previous GP/CDT team • CDT full assessment with positive swabs and contract • Harm minimisation – Hep C /HIV/Hep B testing, accelerated Hep A /B vaccination schedule. • Overdose prevention advice • Needle exchange scheme at local chemist and needle bin at Ellen Badger Hospital

  12. In practice… • Maintenance until stability achieved • Regular health check – aging population! COPD/Hep C/Alcoholic cardiomyopathy • Contraception and STIs • Cascade alerts re contaminated batches • Boundaries – not punitive but consistent • Negotiation re pick ups • Life without drugs – the role of ‘meaningful activity’

  13. In practice • QOF and chronic disease - depression screening questions • Evidence that PHQ9 and GAD score can be used with patients within addiction services. • Improved flexible working with CMHT especially IAPT

  14. Ongoing care • RCGP guidelines: • Treatment reviewed at every contact and needs to be re-examined more formally every 3-4 months to measure improvements in health and wellbeing and to monitor any use of alcohol or drugs and given support to make changes • Toxicology screen frequently at start of treatment and when stabilised two to four times a year.

  15. High dose Methadone and risk of sudden cardiac death • Torsades de pointes – ventricular arrhythmia associated with prolonged QTc interval • All those on methadone 100mg or above • Those on methadone + additional factors • Lithium, SSRI, TCA, sotalol, venlafaxine, macrolides • Structural heart disease • Offer ECG – if normal, repeat every 12 months • If abnormal – discuss change in script, reduction in dose, consider cardiology referral

  16. In practice • Therapeutic relationship requires trust and continuity • Continuity of CDT worker and GP • Positive attitude from Primary health care team • Good communication – plans in place, swab results available • Flexibility of CDT worker and GP • Engagement and signposting for other psychosocial issues • Consistency in approach by other GPs in the practice. Annual clinical meeting • Professional peer support

More Related